More Articles

Hospira re-joins Generic Pharmaceutical Association Generics/News | Posted 02/03/2012

Hospira announced on 23 February 2012 that the company had re-joined the Generic Pharmaceutical Association (GPhA). Hospira, self-proclaimed leader in injectable generics, added that it is dedicate...

Apotex clopidogrel at-risk launch costs US$442 million Generics/News | Posted 02/03/2012

Sanofi and Bristol-Myers Squibb (BMS) announced on 8 February 2012 that generic drugmaker Apotex had paid a whopping US$442 million in damages in the Plavix (clopidogrel bisulfate) patent infringem...

GaBI launches GaBI Journal Pharma News | Posted 01/03/2012

- A new information source for generics and biosimilars -

Oncologists urged to embrace biosimilars to help control spiraling costs of cancer care Biosimilars/Research | Posted 24/02/2012

Oncologists have been urged to embrace biosimilar drug substitution to help control the spiraling costs of cancer care. However, they have been warned that the optimal realisation of such a program...

Obama healthcare budget cuts Policies & Legislation | Posted 24/02/2012

US President Barack Obama has announced proposals for fiscal year 2013 which aim to cut the US deficit by US$4 trillion over the next decade. However, drugmakers have reacted with disappointment to...

Prescribing of generic PPIs and statins in Scotland Generics/Research | Posted 24/02/2012

In Scotland, a series of measures have been introduced since 2000 in order to encourage use of generic rather than brand-name proton pump inhibitors (PPIs) and statins [1]. Some of the measures int...

Commission urges Greece to make parallel trade fair Generics/General | Posted 24/02/2012

The European Commission announced on 26 January 2012 that it wanted Greece ‘to establish fair play on parallel importation of medicinal products’.

Sun comes under fire from Pfizer Generics/News | Posted 24/02/2012

Sun Pharmaceutical Industries (Sun Pharma) is coming under fire from Pfizer, as the generics major is sued for violating patents on Pfizer’s Protonix (pantoprazole).